ETRACS CMCI Total Return ETN Series B (UCIB) Stock Overview
Explore ETRACS CMCI Total Return ETN Series B’s financial performance, market position, analyst ratings, and future outlook.
ETRACS CMCI Total Return ETN Series B (UCIB)
Key Financials
Key Financials
Market Cap
29.6M
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
0.00%
UCIB Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of ETRACS CMCI Total Return ETN Series B (AMEX: UCIB) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, ETRACS CMCI Total Return ETN Series B's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of UCIB on the AMEX shows an RSI of 51.32, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $35.66 for the AMEX listing.
Key metrics behind ETRACS CMCI Total Return ETN Series B's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 29.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of UCIB on the AMEX.